Brazil Achieves a Historic Milestone: Blau Farmacêutica Fully Develops One of the World’s Most Advanced Biosimilars Immunotherapies
With drug substance GMP approval from ANVISA and international regulatory progress, access to cancer immunotherapy in Brazil may be fundamentally…
